Comparing the outcomes of non-surgical versus surgical treatment of shoulder fractures with different shoulder replacements

ISRCTN ISRCTN85422168
DOI https://doi.org/10.1186/ISRCTN85422168
ClinicalTrials.gov number NCT06444828
Secondary identifying numbers IRSTA 123456
Submission date
03/07/2021
Registration date
08/07/2021
Last edited
30/12/2024
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The optimal treatment of complex shoulder fracture is controversial. In general, non-surgical treatment is recommended for older patients, but results are often unsatisfying. Therefore different surgical approaches have been tried to improve outcomes for this group of patients. Reverse shoulder arthroplasty has shown promising results for these types of fractures and changes in the design of the implant might improve outcomes further. The aim of this study is to compare the outcomes of complex shoulder fractures after non-surgical versus surgical treatment and compare two different types of implants.

Who can participate?
Patients aged above 60 years with complex shoulder fractures

What does the study involve?
Participants are randomly allocated to one of three groups:
Group 1: non-surgical treatment (rehabilitation only)
Group 2: surgical replacement with a 155-degree inclination angle
Group 3: surgical replacement with a 135-degree inclination angle
Participants are followed up after 3, 12 and 24 months. All groups also receive a similar standard rehabilitation program. They have to fill in on questionnaires and measurements of their range of movement and strength will be taken, as well as x-rays.

What are the possible benefits and risks of participating?
There is neither a definite benefit nor risk of participating. All patients who meet the inclusion criteria will be offered the same treatment non-surgical or surgical options, even if they choose not to participate in this study. The treatments are common procedures, the only difference is patients can't choose the treatment.

Where is the study run from?
Hospital South West Jutland (Denmark)

When is the study starting and how long is it expected to run for?
April 2021 to September 2027

Who is funding the study?
Hospital South West Jutland (Denmark)

Who is the main contact?
Dr Klaus Hanisch
klaus.hanisch@rsyd.dk

Contact information

Dr Klaus Hanisch
Scientific

Hannevangvej 65
Billum
6852
Denmark

ORCiD logoORCID ID 0000-0002-8664-3773
Phone +45 (0)20535332
Email klaus.hanisch@rsyd.dk

Study information

Study designRandomized single-blinded controlled study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet 40119_PIS.docx
Scientific titleOutcome following reverse shoulder arthroplasty for acute proximal humerus fractures with different humerus inclination angles versus non-surgical treatment
Study objectivesThe aim of the study is to compare the outcomes of different designed reverse shoulder arthroplasty (RSA) versus conservative treatment of proximal humeral fracture (PHF) Neer type III or IV / AO B2, C2.
Ethics approval(s)Approved 01/09/2021, the scientific ethic committee of the region south Denmark (De Videnskabsetiske Komite, Regionshuset, Damhaven 12, 7100, Vejle, Denmark; +45 (0)76638221, +45 (0)29201203; komite@rsyd.dk), ref: 82397
Health condition(s) or problem(s) studiedProximal humeral fracture type Neer 3 & 4
Intervention90 patients are randomized to one of three groups:
Group 1: non-surgical treatment (rehabilitation only)
Group 2: surgical replacement with a 155-degree inclination angle
Group 3: surgical replacement with a 135-degree inclination angle

Participants are followed up at 3, 12 and 24 months.
Intervention typeProcedure/Surgery
Primary outcome measureMeasured at 3, 12 and 24 months:
1. Quality of life measured using the Western Ontario Osteoarthritis score (WOOS)
2. Pain, activities of daily living, range of movement and strength measured by specially trained physiotherapists with the Constant Murley (CS) score
3. Quality of life measured using the Subjective Shoulder Value (SSV) questionnaire
4. Bone healing response evaluated using x-ray as union/non-union/pseudarthrosis in the non-surgical group and status of healing of the tuberosities as healed, displaced over 5 mm or resorbed
Secondary outcome measuresComplications and revisions reported in medical records within the 2 years of follow up
Overall study start date01/04/2021
Completion date01/09/2027

Eligibility

Participant type(s)Patient
Age groupSenior
Lower age limit60 Years
SexBoth
Target number of participants90
Key inclusion criteria1. Proximal humerus fracture type Neer 3 & 4
2. Older than 60 years
Key exclusion criteria1. Age younger than 60 years
2. Conditions where surgery is mandatory
3. Patients who can't answer questions because of the effects of dementia
Date of first enrolment01/09/2021
Date of final enrolment01/09/2025

Locations

Countries of recruitment

  • Denmark

Study participating centre

Hospital South West Jutland
Finsensgade 35
Esbjerg
6700
Denmark

Sponsor information

Hospital South West Jutland
Hospital/treatment centre

c/o Christina Staal
Orthopedic Department
Finsengade 35
Esbjerg
6700
Denmark

Phone +45 (0)79182111
Email Christina.Staal@rsyd.dk
Website https://www.sydvestjysksygehus.dk
ROR logo "ROR" https://ror.org/03pzgk858

Funders

Funder type

Hospital/treatment centre

Hospital South West Jutland

No information available

Results and Publications

Intention to publish date01/09/2028
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed international journal
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Dr Klaus Hanisch (klaus.hanisch@rsyd.dk).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 04/08/2021 No Yes
Protocol file 04/08/2021 No No
Protocol article 09/10/2024 30/12/2024 Yes No

Additional files

40119_PROTOCOL.docx
40119_PIS.docx

Editorial Notes

30/12/2024: Publication reference and ClinicalTrials.gov number added.
01/09/2021: The ethics approval was added.
04/08/2021: The protocol and participant information sheet were uploaded as additional files.
06/07/2021: Trial's existence confirmed by the scientific ethic committee of the region south Denmark.